Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes
(Q51556998)
scientific article
scientific article
Language:
Current Data About
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes